Insider Trading Alert - APO, KEX, TRS, OPK And THC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 18, 2013, 188 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $499.99 to $6,605,383,701.40.

Highlighted Stocks Traded by Insiders:

Apollo Global Management (APO) - FREE Research Report

Harris Joshua who is Senior Managing Director at Apollo Global Management sold 555,491 shares at $30.23 on Nov. 18, 2013. Following this transaction, the Senior Managing Director owned 1.4 million shares meaning that the stake was reduced by 28.88% with the 555,491 share transaction.

The shares most recently traded at $30.30, up $0.07, or 0.24% since the insider transaction. Historical insider transactions for Apollo Global Management go as follows:

  • 4-Week # shares bought: 900
  • 12-Week # shares bought: 900
  • 24-Week # shares bought: 900
  • 24-Week # shares sold: 33,810

The average volume for Apollo Global Management has been 954,800 shares per day over the past 30 days. Apollo Global Management has a market cap of $4.3 billion and is part of the financial sector and financial services industry. Shares are up 74.37% year to date as of the close of trading on Monday.

Apollo Global Management, LLC is a publicly owned investment manager. The firm primarily provides its services to pension and endowment funds, institutional investors, individual investors, pooled investment vehicles, and corporations. The stock currently has a dividend yield of 13.07%. The company has a P/E ratio of 7.2. Currently there are 11 analysts that rate Apollo Global Management a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on APO - FREE

TheStreet Quant Ratings rates Apollo Global Management as a sell. The area that we feel has been the company's primary weakness has been its feeble growth in its earnings per share. Get the full Apollo Global Management Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Kirby (KEX) - FREE Research Report

Dragg Ronald A who is Vice President and Controller at Kirby sold 1,473 shares at $95.06 on Nov. 18, 2013. Following this transaction, the Vice President and Controller owned 10,034 shares meaning that the stake was reduced by 12.8% with the 1,473 share transaction.

Grzebinski David W who is Executive VP and CFO at Kirby sold 5,000 shares at $95.07 on Nov. 18, 2013. Following this transaction, the Executive VP and CFO owned 28,984 shares meaning that the stake was reduced by 14.71% with the 5,000 share transaction.

The shares most recently traded at $93.91, down $1.16, or 1.24% since the insider transaction. Historical insider transactions for Kirby go as follows:

  • 12-Week # shares sold: 200,000
  • 24-Week # shares sold: 215,196

The average volume for Kirby has been 286,600 shares per day over the past 30 days. Kirby has a market cap of $5.4 billion and is part of the services sector and transportation industry. Shares are up 50.8% year to date as of the close of trading on Monday.

Kirby Corporation, through its subsidiaries, provides marine transportation and diesel engine services primarily in the United States. Its Marine Transportation segment provides transportation services for the inland and coastal markets. The company has a P/E ratio of 21.9. Currently there are 8 analysts that rate Kirby a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KEX - FREE

TheStreet Quant Ratings rates Kirby as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Kirby Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

TriMas Corporation (TRS) - FREE Research Report

Sherbin Joshua A who is Vice President & Secretary at TriMas Corporation sold 10,616 shares at $37.34 on Nov. 18, 2013. Following this transaction, the Vice President & Secretary owned 54,681 shares meaning that the stake was reduced by 16.26% with the 10,616 share transaction.

The shares most recently traded at $36.16, down $1.18, or 3.26% since the insider transaction. Historical insider transactions for TriMas Corporation go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 100
  • 12-Week # shares sold: 5,000
  • 24-Week # shares bought: 100
  • 24-Week # shares sold: 60,500

The average volume for TriMas Corporation has been 297,500 shares per day over the past 30 days. TriMas Corporation has a market cap of $1.7 billion and is part of the industrial goods sector and industrial industry. Shares are up 30.82% year to date as of the close of trading on Monday.

TriMas Corporation designs, manufactures, and distributes various products for commercial, industrial, and consumer markets worldwide. The company has a P/E ratio of 28.6. Currently there are 4 analysts that rate TriMas Corporation a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on TRS - FREE

TheStreet Quant Ratings rates TriMas Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full TriMas Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 16,100 shares at $10.04 on Nov. 18, 2013. Following this transaction, the CEO & Chairman owned 137.1 million shares meaning that the stake was reduced by 0.01% with the 16,100 share transaction.

The shares most recently traded at $9.47, down $0.57, or 5.97% since the insider transaction.

The average volume for Opko Health has been 4.8 million shares per day over the past 30 days. Opko Health has a market cap of $4.1 billion and is part of the health care sector and health services industry. Shares are up 99.58% year to date as of the close of trading on Monday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share and deteriorating net income. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Tenet Healthcare (THC) - FREE Research Report

Pitts Keith B who is Vice Chairman at Tenet Healthcare bought 6,250 shares at $43.14 on Nov. 18, 2013. Following this transaction, the Vice Chairman owned 18,750 shares meaning that the stake was reduced by 50% with the 6,250 share transaction.

The shares most recently traded at $41.05, down $2.09, or 5.09% since the insider transaction. Historical insider transactions for Tenet Healthcare go as follows:

  • 4-Week # shares bought: 12,500
  • 12-Week # shares bought: 12,500
  • 12-Week # shares sold: 24,873
  • 24-Week # shares bought: 12,500
  • 24-Week # shares sold: 24,873

The average volume for Tenet Healthcare has been 1.8 million shares per day over the past 30 days. Tenet Healthcare has a market cap of $4.2 billion and is part of the health care sector and health services industry. Shares are up 29.26% year to date as of the close of trading on Monday.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. Currently there are 8 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on THC - FREE

TheStreet Quant Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share and revenue growth. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Tenet Healthcare Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Global Stocks Hold Gains as North Korea Response on Talks Soothes Nerves

Global Stocks Hold Gains as North Korea Response on Talks Soothes Nerves

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists